10 Neurocrine Biosciences regulatory affairs leaders
Ingrid Delaet, Chief Regulatory Officer, is the most senior of these Neurocrine Biosciences regulatory affairs leaders, and others on the list now hold titles in regulatory strategy, regulatory CMC and regulatory advertising and promotion. A reader can learn how regulatory affairs leaders work at Neurocrine Biosciences from people who have held the role.
Professionals to explore
Adam Uchimoto
LinkedInExperience: Senior Director, Regulatory Strategy · Neurocrine Biosciences
Adam Uchimoto has been Senior Director, Regulatory Strategy at Neurocrine Biosciences since July 2026, based in San Diego County, and also held Director, Global Regulatory Affairs there from 2022 to 2026. Adam Uchimoto was Associate Director Regulatory Affairs at Jazz Pharmaceuticals from 2020 to 2022.
Alessandro Lobbia
LinkedInExperience: Former Executive Director, Regulatory CMC · Neurocrine Biosciences
Alessandro Lobbia was Executive Director, Regulatory CMC at Neurocrine Biosciences from September 2015 to May 2020, based in San Diego. Alessandro Lobbia has been Vice President, Regulatory CMC at Pacira BioSciences, Inc. since June 2020, where the profile says the role oversees and manages the company's Regulatory CMC departmental activities.
Amanda (Omlor) Richter, MS RAC
LinkedInExperience: Executive Director, Regulatory Affairs · Neurocrine Biosciences
Amanda Richter has been Executive Director, Regulatory Affairs at Neurocrine Biosciences since January 2020, based in San Diego. Amanda Richter was Senior Director, Regulatory Affairs at Tocagen Inc. from 2011 to 2020 and Manager, Regulatory Affairs at Biogen from 2008 to 2011.
Heather Welsh, RAC
LinkedInExperience: Senior Director, Regulatory CMC · Neurocrine Biosciences
Heather Welsh has been Senior Director, Regulatory CMC at Neurocrine Biosciences since August 2026, based in San Diego. At Neurocrine Biosciences, Heather Welsh was Director, Regulatory CMC from 2022 to 2026, Senior Manager, Regulatory CMC from 2020 to 2022 and Regulatory Affairs Manager, CMC from 2018 to 2020.
Ingrid Delaet
LinkedInExperience: Chief Regulatory Officer · Neurocrine Biosciences
Ingrid Delaet has been Chief Regulatory Officer at Neurocrine Biosciences since October 2022, based in San Diego. Ingrid Delaet was Vice President Regulatory Affairs at Neurocrine Biosciences from 2021 to 2022 and Senior Vice President Regulatory Affairs at Intercept Pharmaceuticals from 2019 to 2021.
Leighann Timbs
LinkedInExperience: Former Senior Director, Regulatory Strategy · Neurocrine Biosciences
Leighann Timbs was Senior Director, Regulatory Strategy at Neurocrine Biosciences from August 2022 to August 2024 and Director, Regulatory Strategy there from 2021 to 2022, based in San Diego County. Leighann Timbs has been Executive Director, Regulatory Affairs at Crinetics Pharmaceuticals since June 2026.
Maria Chavez
LinkedInExperience: Director, Regulatory Business Operations · Neurocrine Biosciences
Maria Chavez has been Director, Regulatory Business Operations at Neurocrine Biosciences since August 2026, based in the San Diego Metropolitan Area. At Neurocrine Biosciences, Maria Chavez was Associate Director, Regulatory Business Operations from 2024 to 2026, Sr. Manager, Regulatory Business Operations from 2023 to 2024 and Senior Regulatory Affairs Project Manager from 2021 to 2023.
Patrick Frey
LinkedInExperience: Executive Director, Regulatory Strategic Operations · Neurocrine Biosciences
Patrick Frey has been Executive Director, Regulatory Strategic Operations at Neurocrine Biosciences since February 2026, based in the San Diego Metropolitan Area, and also held Senior Director, Regulatory Policy there from 2024 to 2026. Patrick Frey was Director (US Lead), Global Regulatory and R&D Policy at Amgen from 2018 to 2024 and Chief of Staff/Deputy Director of Operations, Office of New Drugs at FDA from 2016 to 2018.
Riley Stelzer, PharmD
LinkedInExperience: Director, Regulatory Affairs Advertising and Promotion · Neurocrine Biosciences
Riley Stelzer has been Director, Regulatory Affairs Advertising and Promotion at Neurocrine Biosciences since February 2023, based in San Diego. At Neurocrine Biosciences, Riley Stelzer was Associate Director in the same area from 2022 to 2023 and Senior Manager from 2020 to 2022, and was Manager, Regulatory Affairs Advertising, Promotion and Labeling at Agios Pharmaceuticals from 2019 to 2020.
sang Lee
LinkedInExperience: Director Reg CMC · Neurocrine Biosciences
sang Lee has been Director Reg CMC at Neurocrine Biosciences since August 2023, based in Aliso Viejo, California. sang Lee was Director Reg CMC at Turning Point Therapeutics from 2022 to 2023 and Associate Director, Regulatory Affairs, CMC at BeiGene from 2020 to 2022.
Choose the right perspective
Match the area named in a person's title, such as regulatory strategy, CMC, operations or advertising and promotion, to the decision in front of you. Weigh whether a current leader or someone who held the role in past years gives the perspective you need.
Questions to take into the conversation
- 01What did you focus on first when you took on your regulatory affairs role at Neurocrine Biosciences?
- 02How do you set priorities across the regulatory work you are responsible for?
- 03What has your own work at Neurocrine Biosciences taught you about leading regulatory affairs staff?
Reaching Neurocrine Biosciences regulatory affairs leaders
How can I contact one of these Neurocrine Biosciences regulatory affairs leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Neurocrine Biosciences, based on profile data retrieved on October 25, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Neurocrine Biosciences regulatory affairs leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Neurocrine Biosciences regulatory affairs leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.